Allergy Immunotherapies Market Scope And Analysis

  • Report Code : TIPRE00008219
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Allergy Immunotherapies Market Scope and Analysis Report by 2031

Buy Now


Allergy Immunotherapies Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2.16 Billion
Market Size by 2031 US$ 5.11 Billion
Global CAGR (2023 - 2031) 9.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Treatment
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
By Type
  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ALK Abell A S
  • Nestl Health Science
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy B V
  • Johnson and Johnson Services Inc
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics
  • Allergy Immunotherapies Market News and Recent Developments

    The allergy immunotherapies market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for allergy immunotherapies and strategies:

    • In August 2020, Nestlé Health Science acquired Aimmune Therapeutics. Aimmune's approved therapy Palforzia would expand Nestlé Health Science portfolio with first and only FDA-approved treatment to help reduce the frequency and severity of allergic reactions to peanuts in children. (Source: Company Press Release)
    • In September 2023, Stallergenes Greer entered into an agreement with Nestlé Health Science to harness the peanut allergy oral immunotherapy treatment Palforzia.  (Source: Company Press Release)

    Allergy Immunotherapies Market Report Coverage and Deliverables

    The “Allergy Immunotherapies Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles